Gefticip - 250 Mg Geftinib Tablets For Non-small Cell Lung Cancer Treatment | Anti-cancer Egfr Tyrosine Kinase Inhibitor

We are engaged in offering excellent quality Gefticip Tablets to our valuable clients. Gefticip - Gefitinib belongs to a class of anti-cancer medications called epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors. Gefticip belonging to a class of anti-cancer medications called epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors and it is used for the treatment of non-small cell lung cancer. It works by targeting the mutant protein in the cancerous cells and that is how it destroys the cancerous cells.

Indication: Gefticip is used for the treatment of non-small cell lung cancer.

AVAILABLE AS: 250 mg tablets.